Cita APA

Álamo, M. d. C., Ochenduszko, S., Crespo, G., Corral, M., Oramas, J., Sancho, P., & Muñoz Couselo, E. (2021). Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.

Citación estilo Chicago

Álamo, Mª del Carmen, Sebastian Ochenduszko, Guillermo Crespo, Mónica Corral, Juana Oramas, Pilar Sancho, y Eva Muñoz Couselo. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. 2021.

Cita MLA

Álamo, Mª del Carmen, et al. Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice. 2021.